Viewing nowCombinationTwinon Tablets 40/5 mg
Telmisartan 40mg · Telmisartan Powder 23.9% 167.36mg +1 more
Tablet · Prescription medication · Combination
Korea Chorus Co., Ltd.

MFDS item code 201706876 · Approved 2017.08.29 · Insurance code 647204430
Treatment of essential hypertension uncontrolled by monotherapy
This medication can effectively control blood pressure in patients with essential hypertension who are not sufficiently controlled with amlodipine or telmisartan monotherapy. Essential hypertension is characterized by persistently high blood pressure which increases the risk of cardiovascular diseases, making appropriate medication treatment extremely important. This product combines the advantages of both medications to improve blood pressure control and helps in the prevention of cardiovascular complications, making it a suitable treatment option for patients with challenging blood pressure management.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time every day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual ingredients (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual ingredients as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience (limited to this medicine 40/5 mg and 80/10 mg). ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and gradually increase the dose. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section ‘3. Patients requiring caution when administered.’) In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication can pose a serious risk to the fetus during pregnancy, especially in the second and third trimesters; therefore, it should not be used by women who are pregnant or might become pregnant. This drug is contraindicated in patients with certain diseases, such as liver disease, severe hypotension, heart failure, unstable conditions after acute myocardial infarction, and biliary obstructive disease. Particular caution is needed for patients with primary aldosteronism, heart valve disease, impaired liver function, gastrointestinal disease, renal artery hypertension, patients undergoing dialysis, and the elderly when using this drug. Common symptoms while taking this medication may include dizziness and peripheral edema, but occasionally fainting or severe side effects can occur; therefore, consult medical personnel if any abnormal symptoms appear. This medication should not be taken during pregnancy, and it should be stopped immediately if pregnancy is confirmed, switching to another safe treatment method. As this medication lowers blood pressure, patients with low fluid or salt levels may experience hypotension, so it is essential to check the condition carefully before use and observe cautiously. This drug may increase potassium levels in the blood; hence, patients at risk of hyperkalemia should regularly monitor potassium levels through blood tests. Patients with impaired renal function may experience worsening kidney function while taking this drug; thus, regular blood tests to monitor kidney status are recommended. Patients with heart disease may see an increased risk of angina or myocardial infarction; therefore, they should be attentive to any changes in symptoms after taking this medication. This drug can cause drowsiness or dizziness, so caution should be exercised when driving or operating dangerous machinery while taking it. There may be interactions with other medications, so especially when taken with digoxin, lithium, warfarin, certain anti-inflammatory analgesics, or grapefruit juice, it is important to consult medical personnel. Breastfeeding women are advised not to take this drug, and special caution is necessary when treating children or the elderly. In case of overdose, serious symptoms such as hypotension, changes in heart rate, or kidney failure may appear; therefore, immediate medical treatment should be sought.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that does not allow light to enter. Additionally, it is preferable to store the drug at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the drug's efficacy and safety.
For domestic use: white or whitish rectangular tablets For export: white and light gray double-layer oval tablets with both sides convex.
30 tablets/box [(10 tablets/Alu-Alu * 3)], 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Telmisartan Powder 23.9% 167.36mg +1 more
Tablet · Prescription medication · Combination
Korea Chorus Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Telmisartan 40mg +1 more
Tablet · Prescription medication · Combination
Kujoo Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Telmisartan 80mg +1 more
Tablet · Prescription medication · Combination
Gooju Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Telmisartan 40mg +1 more
Tablet · Prescription medication · Combination
Gujoo Pharmaceutical Co., Ltd.
CombinationTelmisartan 167.36mg · Telmisartan Powder 23.9% 167.36mg +1 more
Tablet · Prescription medication · Combination
Korea Chorus Co., Ltd.
CombinationTelmisartan 80mg · Telmisartan Powder 23.9% 334.72mg +1 more
Tablet · Prescription medication · Combination
Korea Chorus Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.